Overview
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
Status:
Completed
Completed
Trial end date:
2010-06-01
2010-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
We will determine if linezolid inhibits cellular activation and production of pro-inflammatory cytokines, providing mechanistic rationale for its clinical efficacy and the justification for further investigations in S. Aureus sepsis.Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of UtahCollaborator:
PfizerTreatments:
Linezolid
Vancomycin
Criteria
Inclusion Criteria:- Healthy, taking no medications, and not recently hospitalized
Exclusion Criteria:
- Infection (active)